Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Chinese Patent Office
Queensland Health
Colorcon
Healthtrust
Johnson and Johnson
Harvard Business School
Cantor Fitzgerald

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088487

« Back to Dashboard

NDA 088487 describes HYDROXYZINE PAMOATE, which is a drug marketed by Barr, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, and Watson Labs, and is included in thirty-four NDAs. It is available from thirty-five suppliers. Additional details are available on the HYDROXYZINE PAMOATE profile page.

The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.
Summary for 088487
Tradename:HYDROXYZINE PAMOATE
Applicant:Barr
Ingredient:hydroxyzine pamoate
Patents:0
Therapeutic Class:Antiemetics
Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 088487
Suppliers and Packaging for NDA: 088487
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088487 ANDA Teva Pharmaceuticals USA, Inc. 0555-0302 N 0555-0302-02
HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088487 ANDA Teva Pharmaceuticals USA, Inc. 0555-0302 N 0555-0302-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 50MG HCL
Approval Date:Jun 15, 1984TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Chubb
Deloitte
Medtronic
Citi
Julphar
Baxter
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.